Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma

V-type immunoglobulin domain-containing suppressor of T cell activation (VISTA) is considered as an immunosuppressive factor and potential therapeutic target for anticancer therapy. However, little is known about VISTA expression and its role in immunosuppression in multiple myeloma (MM). In this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shuxin, Zhao, Yujie, Liao, Pengjun, Wang, Jinghua, Li, Zhiyan, Tan, Jiaxiong, Zha, Xianfeng, Chen, Shaohua, Li, Yangqiu, Zhong, Liye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684650/
https://www.ncbi.nlm.nih.gov/pubmed/36439426
http://dx.doi.org/10.3389/fonc.2022.1014904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9684650/
https://www.ncbi.nlm.nih.gov/pubmed/36439426
http://dx.doi.org/10.3389/fonc.2022.1014904

Ejemplares similares